Next-Generation Influenza Vaccine R&D Landscape: Analysis

Overview

Conducted analysis of the global pipeline of next-generation influenza vaccine candidates and the broader R&D landscape. This work contributed analytical inputs to the Full Value of Improved Influenza Vaccines Assessment (FVIVA) and characterized progress toward improved influenza vaccines.

Role

Lead analyst and author of multiple publications on next-generation influenza vaccines; contributing author to the FVIVA report.

Key Contributions & Outputs

• Pipeline analysis of next-generation influenza vaccine candidates

• Mapping of emerging technological approaches and vaccine platforms relative to current vaccines

• Identification of R&D gaps

• Analytical and writing inputs to the FVIVA project

• Assessment of progress toward improved influenza vaccine targets

Published analysis: Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact

Full Value of Improved Influenza Vaccine Assessment (FVIVA)

Impact

Findings informed global discussions on influenza vaccine innovation and efforts to advance improved influenza vaccines and pandemic preparedness.